ArticleACS omega2025
Comparison of the Human Plasma Peptides from the Fit of Fragmentation Spectra versus Accurate Monoisotopic Precursor Mass.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In nature, ionized peptides with heavy isotopes and hydrogen rearrangements show a broad mass distribution with signals at discrete delta mass values from -3 to +5 Da by mass spectrometry (MS). For many peptides, the intensity of the +1 or +2 Da isotope exceeds the signal from the monoisotopic mass. Therefore, there is a need for a method that improves peptide identification from heavy isotopes or hydrogen rearrangements based on the fit of tandem mass spectra. Peptides may be identified using an accurate monoisotopic precursor mass with ≤0.1 Da. However, many peptides with heavy isotopes and H-loss can be identified and enumerated based on the fit of their MS/MS spectra alone in the absence of an accurate precursor monoisotopic mass (i.e., ± 3 Da) using the X!TANDEM MS/MS fitting algorithm. In this study, human plasma samples were analyzed with a highly resolving axially harmonic orbital ion trap (OIT) and a sensitive linear quadrupole ion trap (LIT). The MS/MS fragmentation spectra from the OIT can be fit to peptides from the monoisotopic (±0.1 Da) as well as all other precursor masses with a wide mass tolerance (±3 Da). The resulting delta mass distribution can then be plotted and compared to the predicted distribution of heavy isotopes and hydrogen rearrangements to provide a direct biophysical prediction and test the validity of the fit determined by accepting the best-fit MS/MS spectra. The OIT instrument, which has greater resolution, was sampled at 30 nL per minute, while the more sensitive LIT was sampled at 200 nL per minute. The MS/MS spectra generated by each instrument were fit to peptides within a wide window (±3 Da) using the rigorous X!TANDEM algorithm. The OIT and LIT results were compared in an SQL Server database and corrected against analytical and statistical controls. The delta mass distribution of the peptides with hydrogen rearrangements and heavy isotopes was determined from the fit MS/MS spectra using the R statistical program. The OIT sampled MS and MS/MS spectra from the high-intensity precursor ions by focusing on E7 to E9 detector counts. In contrast, the LIT sampled a range of precursor ion intensities focused from E4 to E7 and thus reached lower ion intensity values. As expected, the precursor mass [M + H]
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.